What Researchers Did
Researchers conducted a randomized controlled trial with 50 subjects to assess cognitive and PTSD symptom changes in traumatic brain injury patients receiving hyperbaric oxygen therapy (2.4 atm abs) versus a sham treatment (1.3 atm abs).
What They Found
Overall, no statistically significant differences were found between the hyperbaric oxygen and sham groups in cognitive scores or PTSD symptoms, though both groups showed improvement. However, subgroup analyses revealed improvements in the treatment group compared to sham for specific factors like concussion history, visual memory, and processing.
What This Means for Canadian Patients
Canadian patients with traumatic brain injury may not see a general benefit from hyperbaric oxygen therapy based on these findings. However, future research might identify specific patient profiles, such as those with certain concussion histories or cognitive deficits, who could potentially benefit from this treatment.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this study is the lack of overall statistically significant differences between groups, with positive findings primarily observed in subgroup analyses which require further validation.